T/R potency <5% [Regulatives / Guidelines]

posted by Achievwin – US, 2022-09-07 20:22 (1014 d 23:57 ago) – Posting: # 23275
Views: 5,383

Colleagues:

Somewhere in the Bioequivalence guidance I remembered that when designing the studies we try to keep T/R potency +/-5%. Can someone point out where this kind of condition existed, (latest guidance has no mention of this)

Thanks in advance for your guidance,

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
31 visitors (0 registered, 31 guests [including 14 identified bots]).
Forum time: 20:20 CEST (Europe/Vienna)

Truth and clarity are complementary.    Niels Bohr

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5